InSphero at SBI2 2025!
Don't miss us at SBI2 2025 in Boston, Massachusetts! This leading conference in high content imaging and informatics will enhance our understanding on how apply these technologies in new way that drive drug discovery.
Join us and the Society for Biomolecular Imaging and Informatics as we take a closer look at advancing technological innovations and complex 3D models. SBI2 2025 is taking place from Monday, October 27th to Wednesday, October 29th.
Quick navigation
Meet our Team at SBI2 2025


Judi Wardwell-Swanson
Senior Scientist Consultant
Judi Wardwell-Swanson
Senior Scientist Consultant
Judi Wardwell-Swanson is a Senior Scientist consultant at InSphero and past-president of the Society of Biomolecular Imaging and Informatics (SBI2) board of directors. At InSphero her work is focused on the development of high content imaging applications utilizing 3D human microtissue models. Judi also has accumulated more than 25 years of experience in the pharma industry and has a long-standing interest in the utilization of genomics and imaging technologies to help drive drug discovery. During her tenure at Bristol-Myers Squibb, her team conducted phenotypic screens in physiologically-relevant cell models with an emphasis on the identification and validation new drug targets using a variety of genomics and chemical biology approaches. Judi is also the author of several journal articles and a book chapter on high content imaging-related topics such as HCS data management, analysis of multidimensional imaging data, and 3D imaging/analysis of multicellular spheroids and micro-tissue models.




Ozlem Yavas Grining
Senior Scientist, Technology and Platforms
Ozlem Yavas Grining
Senior Scientist, Technology and Platforms
Özlem is a Senior Scientist at InSphero with a Ph.D. in Physics and over 10 years of experience in multidisciplinary research spanning cell biology, microfluidics, automation, and imaging. At InSphero, she focuses on developing high-content imaging assays and 3D image analysis pipelines for spheroid-based drug discovery applications. While focusing on technology development and HCI endpoints, she is also keen on improving process efficiency through automation. Her background in both engineering and life sciences allows her to contribute to various aspects of preclinical research and technology development in drug discovery.




Tamara Häfeli
Senior Research Associate, Technology and Platforms
Tamara Häfeli
Senior Research Associate, Technology and Platforms
Tamara Häfeli holds an MSc in Biotechnology from ETH Zurich (Department of Biosystems Science and Engineering). Since 2021, she has been working as a Senior Research Associate at InSphero AG, specializing in microphysiological systems and organ-on-a-chip technologies. Her work focuses on the development of 3D imaging techniques as well as quantitative image and data analysis to advance preclinical research and in vitro modeling.


Poster at SBI2 2025
Multiparametric assays in 3D human liver microtissues: towards multiplexed in vitro NAMs for drug-induced liver injury (DILI) assessment
Date: Tuesday, October 28th from 4:45 - 7:30 pm
Poster number: #23


Tamara Häfeli
Senior Research Associate, Technology and Platforms
Tamara Häfeli
Senior Research Associate, Technology and Platforms
Tamara Häfeli holds an MSc in Biotechnology from ETH Zurich (Department of Biosystems Science and Engineering). Since 2021, she has been working as a Senior Research Associate at InSphero AG, specializing in microphysiological systems and organ-on-a-chip technologies. Her work focuses on the development of 3D imaging techniques as well as quantitative image and data analysis to advance preclinical research and in vitro modeling.


Scientific Talk at SBI2 2025
Session 3: Technological Innovations in Screening
Machine learning-based, label-free detection of anti-fibrotic effects in a 3D retinal fibrosis model using bright-field imaging
Date: Wednesday, October 29th from 10:45 - 11:15 am
Location: Atlantic Ballroom
Lunch & Learn SBI2 2025
InSphero and Zeiss Lunch & Learn
From Microtissues to Insights: Enhancing Drug Discovery with InSphero and ZEISS
Date: Wednesday, October 29th from 12:45 - 1:45 pm
Location: Salon F


Ozlem Yavas Grining
Senior Scientist, Technology and Platforms
Ozlem Yavas Grining
Senior Scientist, Technology and Platforms
Özlem is a Senior Scientist at InSphero with a Ph.D. in Physics and over 10 years of experience in multidisciplinary research spanning cell biology, microfluidics, automation, and imaging. At InSphero, she focuses on developing high-content imaging assays and 3D image analysis pipelines for spheroid-based drug discovery applications. While focusing on technology development and HCI endpoints, she is also keen on improving process efficiency through automation. Her background in both engineering and life sciences allows her to contribute to various aspects of preclinical research and technology development in drug discovery.



